跳至主要内容
临床试验/NCT03771352
NCT03771352已完成不适用

A Prospective Multi-Center Clinical Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RxLAL) With the Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism

RxSight, Inc.3 个研究点 分布在 2 个国家目标入组 55 人开始时间: 2018年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
RxSight, Inc.
入组人数
55
试验地点
3
主要终点
Uncorrected Distance Visual Acuity (UCDVA) of 20/20 or Better

研究概览

简要总结

For patients undergoing cataract surgery, the purpose of this study is to evaluate a patient's far vision without glasses and quality of vision after implantation and UV treatment of the RxSight Light Adjustable Lens (RxLAL).Following completion of all light treatments, the patient's far vision without glasses and quality of vision will be assessed 6 months postoperatively.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must sign a written Informed Consent form and be willing to undergo cataract surgery for the bilateral implantation of the RxLAL.
  • Greater than the age of 40 on the day the cataract surgery is performed.
  • Preoperative keratometric cylinder of >=0.50 D and <=4.00 D in both eyes.
  • Cataract causing reduction in best corrected distance visual acuity (BCDVA) to a level of 20/32 or worse with or without glare source in both eyes.
  • Willing and able to comply with the requirements for study specific procedures and visits.

排除标准

  • Zonular laxity or dehiscence.
  • Age-related macular degeneration involving the presence of geographic atrophy or soft drusen.
  • Retinal degenerative disorder or macular disorder (other than mild macular degeneration) that is expected to cause future vision loss.
  • History of uveitis
  • Keratoconus or suspected of having keratoconus.
  • Previous corneal or intraocular surgery, except eyes with previous pterygium excision are permitted as long as the pterygium did not extend more than 2mm onto the cornea from the limbus.
  • Serious co-morbid conditions that in the judgement of the investigator makes inclusion in the study not in the best interest of the subject.
  • Subjects taking systemic medications that may increase sensitivity to UV light.
  • Subjects taking a systemic medication that is considered toxic to the retina such as tamoxifen.
  • History of ocular herpes simplex virus
  • History of congenital color vision defect

结局指标

主要结局

Uncorrected Distance Visual Acuity (UCDVA) of 20/20 or Better

时间窗: at 6 months postop

Percent of eyes with monocular uncorrected distance visual acuity of 20/20 or better

次要结局

未报告次要终点

研究者

发起方
RxSight, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验